Mitoxantrone 50mg 50mg | Purity Not Available
Adooq Bioscience
Mitoxantrone is a synthetic antineoplastic anthracenedione (IC50 = 0.42 mM).
More Information Supplier PageSearch Results
Mitoxantrone 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
Mitoxantrone is a synthetic antineoplastic anthracenedione (IC50 = 0.42 mM).
More Information Supplier PageMitoxantrone 100mg 100mg | Purity Not Available
Adooq Bioscience
Mitoxantrone is a synthetic antineoplastic anthracenedione (IC50 = 0.42 mM).
More Information Supplier PageMitotane 500mg 500mg | Purity Not Available
Adooq Bioscience
Mitotane(Lysodren), is an antineoplastic medication used in the treatment of adrenocortical carcinoma.
More Information Supplier PageMitotane 250mg 250mg | Purity Not Available
Adooq Bioscience
Mitotane(Lysodren), is an antineoplastic medication used in the treatment of adrenocortical carcinoma.
More Information Supplier PageMitotane 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
Mitotane(Lysodren), is an antineoplastic medication used in the treatment of adrenocortical carcinoma.
More Information Supplier PageMitotane 1000mg 1000mg | Purity Not Available
Adooq Bioscience
Mitotane(Lysodren), is an antineoplastic medication used in the treatment of adrenocortical carcinoma.
More Information Supplier PageMGCD-265 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
MGCD265 is a multitargeted tyrosine kinase inhibitor that binds to and inhibits the phosphorylation of several RTKs, including the c-Met receptor (HGFR); the Tek/Tie-2 receptor; VEGFR types 1, 2, and 3; and MST1R.
More Information Supplier PageMGCD-265 100mg 100mg | Purity Not Available
Adooq Bioscience
MGCD265 is a multitargeted tyrosine kinase inhibitor that binds to and inhibits the phosphorylation of several RTKs, including the c-Met receptor (HGFR); the Tek/Tie-2 receptor; VEGFR types 1, 2, and 3; and MST1R.
More Information Supplier PageMGCD-265 10mg 10mg | Purity Not Available
Adooq Bioscience
MGCD265 is a multitargeted tyrosine kinase inhibitor that binds to and inhibits the phosphorylation of several RTKs, including the c-Met receptor (HGFR); the Tek/Tie-2 receptor; VEGFR types 1, 2, and 3; and MST1R.
More Information Supplier Page